| Literature DB >> 21215722 |
R Moaddel1, A Rosenberg, K Spelman, J Frazier, C Frazier, S Nocerino, A Brizzi, C Mugnaini, I W Wainer.
Abstract
Cannabinoid receptors, CB1 and CB2, are therapeutic targets in the treatment of anxiety, obesity, movement disorders, glaucoma, and pain. We have developed an on-line screening method for CB1 and CB2 ligands, where cellular membrane fragments of a chronic myelogenous leukemia cell line, KU-812, were immobilized onto the surface of an open tubular (OT) capillary to create a CB1/CB2-OT column. The binding activities of the immobilized CB1/CB2 receptors were established using frontal affinity chromatographic techniques. This is the first report that confirms the presence of functional CB1 and CB2 receptors on KU-812 cells. The data from this study confirm that the CB1/CB2-OT column can be used to determine the binding affinities (K(i) values) for a single compound and to screen individual compounds or a mixture of multiple compounds. The CB1/CB2-OT column was also used to screen a botanical matrix, Zanthoxylum clava-herculis, where preliminary results suggest the presence of a high-affinity phytocannabinoid. Published by Elsevier Inc.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21215722 PMCID: PMC3053438 DOI: 10.1016/j.ab.2010.12.034
Source DB: PubMed Journal: Anal Biochem ISSN: 0003-2697 Impact factor: 3.365